Squamocolumnar junction visibility among cervical cancer screening population in Peru might influence upper age for screening programs

Lopez-Ampuero C.; Hansen N.; Alvarez Larraondo M.; Taipe-Quico R.; Cerna-Ayala J.; Desai K.; Egemen D.; Schiffman M.; Jeronimo J. · Preventive Medicine (2023) · DOI: 10.1016/j.ypmed.2023.107596

Resumen

Cervical cancer screening and treatment of screen positives is an important and effective strategy to reduce cervical cancer morbidity and mortality. In order to have an accurate cervical cancer screening and evaluation of positives, the entire Squamocolumnar Junction (SCJ) must be visible. Throughout the life course, the position of the SCJ changes and affects its visibility. SCJ visibility was analyzed among participants screened at the League Against Cancer Clinic in Lima, Peru. Of the 4247 participants screened, the SCJ was fully visible in 49.7% of participants, partially visible in 23.1%, and not visible in 27.2%. Visibility decreased with age, and by age 45 years old, the SCJ was not fully visible in over 50% of participants. Our results show that a high percentage of participants at ages still recommended for screening do not have totally visible SCJ, and we may need to reconsider the upper age limit for screening and find new strategies for evaluation of those with a positive screening test and non-visible SCJ.